Product Details for NDA 020059
ADENOSCAN (ADENOSINE)
60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: ADENOSINE
Proprietary Name: ADENOSCAN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020059
Product Number: 001
Approval Date: May 18, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ADENOSCAN (ADENOSINE)
Proprietary Name: ADENOSCAN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020059
Product Number: 001
Approval Date: May 18, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: ADENOSINE
Proprietary Name: ADENOSCAN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020059
Product Number: 002
Approval Date: May 18, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ADENOSCAN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020059
Product Number: 002
Approval Date: May 18, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information